Skip to main content

Peer Review reports

From: Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report

Original Submission
4 Oct 2017 Submitted Original manuscript
22 Oct 2017 Author responded Author comments - Liuh Ling Goh
Resubmission - Version 2
22 Oct 2017 Submitted Manuscript version 2
17 Nov 2017 Reviewed Reviewer Report - Corrado Angelini
2 Dec 2017 Reviewed Reviewer Report - Hiroshi Takuma
30 Jan 2018 Author responded Author comments - Liuh Ling Goh
Resubmission - Version 3
30 Jan 2018 Submitted Manuscript version 3
18 Feb 2018 Author responded Author comments - Liuh Ling Goh
Resubmission - Version 4
18 Feb 2018 Submitted Manuscript version 4
20 Mar 2018 Author responded Author comments - Liuh Ling Goh
Resubmission - Version 5
20 Mar 2018 Submitted Manuscript version 5
Publishing
26 Mar 2018 Editorially accepted
3 Apr 2018 Article published 10.1186/s12920-018-0356-8

You can find further information about peer review here.

Back to article page